Edwardf Smith News Today : Breaking News, Live Updates & Top Stories | Vimarsana

  Deaths this week: Margaret Merrill, Robbie Kincaid, Donald Works, Don Burress.   Switzerland County High School held its graduation ceremony for the class of 2011 on a hot, sunny Sunday afternoon, but the large crowd inside the gym witnessed a wonderful commencement.   Jacob Chandler, who graduated form Switzerland County High School in 2008 with academic honors, has graduated from Ivy Tech College with an associates degree in Applied Science.   Jennifer South, a 2007 graduate of Switzerland County High School has graduated from the University of Southern Indiana with a bachelor of scie...

LAVA Therapeutics Provides Business Update and Reports First Quarter Financial Results IPO bolsters balance sheet to $160 million in cash and cash equivalents; expected to fund operations at least into the second half of 2023 Clinical development plans on schedule in both hematological and solid tumor programs Leadership strengthened through key management and board appointments UTRECHT, The Netherlands and PHILADELPHIA, May 20, 2021 (GLOBE NEWSWIRE) -- LAVA Therapeutics N.V. (Nasdaq: LVTX), a biotechnology company focused on applying its expertise in gamma-delta bispecific T cell engagers ...

LAVA Therapeutics Provides Business Update and Reports First Quarter Financial Results GlobeNewswire May 20, 2021 IPO bolsters balance sheet to $160 million in cash and cash equivalents; expected to fund operations at least into the second half of 2023 UTRECHT, The Netherlands and PHILADELPHIA, May 20, 2021 (GLOBE NEWSWIRE) -- LAVA Therapeutics...

LAVA Therapeutics BV: LAVA Therapeutics Provides Business Update and Reports First Quarter Financial Results Clinical development plans on schedule in both hematological and solid tumor programs Leadership strengthened through key management and board appointments UTRECHT, The Netherlands and PHILADELPHIA, May 20, 2021 (GLOBE NEWSWIRE) -- LAVA Therapeutics N.V. (Nasdaq: LVTX), a biotechnology company focused on applying its expertise in gamma-delta bispecific T cell engagers (bsTCEs) to transform cancer therapy, today reported its business update and first quarter 2021 financial results. "We ...